The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
about
The continuing challenges of leprosyZanvil Alexander Cohn 1926-1993Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals.Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae.Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factorOntogeny and expansion of human natural killer cells: clinical implications.Rational immunotherapy with interleukin 2.Antibody- and cell-mediated immune responses of Actinobacillus pleuropneumoniae-infected and bacterin-vaccinated pigs.Contributions of laboratory research to current understanding and management of leprosy.Non-parasite-specific cytokine responses may influence disease outcome following infection.Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.1991 Mack Forster Award Lecture. HLA and disease: from epidemiology to immunotherapy.Zinc and infection: a review.The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes.Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosisRegulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy.Heat-shock protein 60: implications for pathogenesis of and protection against bacterial infections.Bi-directional relationship between pregnancy and periodontal disease.Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis.Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors.Immunotherapy of airborne tuberculosis in mice via the lung-specific delivery of cytokines.Mycobacterium leprae renders Schwann cells and mononuclear phagocytes susceptible or resistant to killer cells.Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections.Cutaneous-malignancy and leprosy. Report of a patient with Mycobacterium leprae and basal cell carcinoma concurrently present in the same lesion.Generation of cytolytic T cells in individuals infected by Mycobacterium tuberculosis and vaccinated with BCG.Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes.Expression and cytokine secretion in the states of immune reactivation in leprosy.
P2860
Q24545809-2496EB6F-B4BF-4F2D-9845-1D763C8094A7Q24680249-936EAE1D-58B1-4410-BBB5-1973F54A5561Q33717893-4E4625D2-C54E-4446-B87B-3D9960A6F4DAQ34297445-7D598CE3-FDDB-411F-8623-AD39F48BEA47Q34313738-9DA26EAF-7CAE-4F13-B6A5-54FF0B1083C4Q34522402-B2D69F3A-E9FC-4BB0-94BF-FFB287973315Q34552167-85DC5A1A-5034-4744-9490-C5A8613E6D4BQ35300674-BC83A964-0AA2-4993-B2AE-C957C128E8CCQ35534436-AA40A06F-4156-4988-A172-4AC337285F62Q35664241-373FB72C-79C5-425E-8BB8-66C270410741Q35732468-2FADB922-E35B-4BCD-81BC-22545BA61FC5Q35823805-081FEA88-4B4E-4160-A83E-5A5BA275102CQ35981919-44D7471F-AB01-422C-947F-2A8ECCA6F67AQ36255320-905F49FA-515D-4184-AA72-F0E486C262B5Q36360987-32165185-39C7-48B8-A5DE-4E9AFD73AA99Q36361254-C383EB29-A0E1-4A29-9785-F14B576BDCF2Q36362922-F7DDEA36-3245-4BD9-A7AC-DA8CBB3466BEQ37119836-11AA39AD-F3EA-4580-8DC6-E1109E5F6460Q37449469-5E2EF767-3702-48D8-892A-2329C20F8F77Q37449508-C4B4191A-B666-491E-958E-1DAEC0471B34Q38067476-4B9697C9-7858-40E5-A927-92BEC351B660Q38883295-87AD3F96-321A-44BB-BC5F-3353D6A78295Q39761568-561459B7-2696-4088-B49D-3DD77CBDDF8DQ40142324-58B5939F-633E-4BAF-B07B-C26D451518D4Q40150013-FC03E1E5-AD03-4698-A842-04E719A8AAAAQ40472445-E230C599-0945-4490-B272-7C3F723A0C9BQ40705561-9B612BEF-4715-4B8F-9256-6E865BC579A3Q41230820-77E195CE-929F-4058-8F37-43522DF6CC92Q42066632-B79D2E7D-C108-4C33-9380-C7130646B7AAQ42941770-34372831-395B-4AEB-85A0-F767CAEA5470Q47758480-9300D3B2-0FAE-4DC0-9942-F71E55A72536
P2860
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մարտին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
The reconstitution of cell-med ...... by recombinant interleukin 2.
@ast
The reconstitution of cell-med ...... by recombinant interleukin 2.
@en
type
label
The reconstitution of cell-med ...... by recombinant interleukin 2.
@ast
The reconstitution of cell-med ...... by recombinant interleukin 2.
@en
prefLabel
The reconstitution of cell-med ...... by recombinant interleukin 2.
@ast
The reconstitution of cell-med ...... by recombinant interleukin 2.
@en
P2093
P2860
P356
P1476
The reconstitution of cell-med ...... by recombinant interleukin 2.
@en
P2093
M Becx-Bleumink
P Converse
R Kiessling
S Teklemariam
T H Ottenhoff
P2860
P304
P356
10.1084/JEM.169.3.893
P407
P577
1989-03-01T00:00:00Z